Synapse - Works

Results (22057)

Randomized, phase Ib/II study of M6620 + avelumab + carboplatin vs standard care (sc) in patients (pts) with platinum-sensitive poly (ADP-ribose) polymerase inhibitor-(PARPi)-resistant ovarian cancer

Meeting Abstract

Banerjee, S.; Vergotte, I.; Colombo, N.; Barve, M.; Grisham, R.; Mehr, K. T.; Falk, M.; Beier, F.; Hennessy, M.; Schroeder, A.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

A phase Ib study of the safety and efficacy of atezolizumab (atezo) + bevacizumab (bev) + cobimetinib (cobi) in patients (pts) with metastatic colorectal cancer (mCRC)

Meeting Abstract

Bendell, J.; Lieu, C.; Raghav, K. P. S.; Argilés, G.; Cubillo, A.; Qu, X.; Yan, Y.; Merchant, M.; Zeuner, H.; Gallo, J. D.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Phase I dose escalation of MSC-1, a humanized anti-LIF monoclonal antibody, in patients (pts) with advanced solid tumours: Updated results

Meeting Abstract

Borazanci, E.; Schram, A.; Brana, I.; Vieito Villar, M.; Garralda, E.; Spreafico, A.; Oliva, M.; Lakhani, N.; Wasserman, R.; Hoffman, K.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Pexidartinib (Pex) for locally advanced tenosynovial giant cell tumour (TGCT): Characterization of hepatic adverse reactions (ARs)

Meeting Abstract

Bauer, S.; Lewis, J. H.; Gelderblom, H.; van de Sande, M.; Stacchiotti, S.; Healey, J. H.; Tap, W. D.; Wagner, A. J.; Pousa, A. L.; Druta, M.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study

Meeting Abstract

Alsina, M.; Tabernero, J.; Arkenau, H. T.; Squadroni, M.; Doi, T.; Faustino, C.; Ghidini, M.; Mansoor, W.; Shitara, K.; Van Cutsem, E.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Primary renal tumour shrinkage in patients (pts) who did not undergo upfront cytoreductive nephrectomy (uCN): Subgroup analysis from the phase III JAVELIN Renal 101 trial of first-line avelumab + axitinib (A + Ax) vs sunitinib (S) for advanced renal cell carcinoma (aRCC)

Meeting Abstract

Albiges, L.; Rini, B. I.; Haanen, Jbag; Motzer, R. J.; Kollmannsberger, C. K.; Negrier, S.; Nole, F.; Bedke, J.; Bilen, M. A.; Nathan, P.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase III study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial

Meeting Abstract

Abou-Alfa, G. K.; Borbath, I.; Clarke, S. J.; Hitre, E.; Louvet, C.; Macarulla, T.; Oh, D. Y.; Spratlin, J. L.; Valle, J. W.; Weiss, K. H.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer

Journal Article

Kopetz, S.; Grothey, A.; Yaeger, R.; Van Cutsem, E.; Desai, J.; Yoshino, T.; Wasan, H.; Ciardiello, F.; Loupakis, F.; Hong, Y. S.; more...
New England Journal of Medicine (2019)

Fulltext@MSK | Save

Imaging patients with metastatic castration-resistant prostate cancer using (89)Zr-DFO-MSTP2109A anti-STEAP1 antibody

Journal Article

Carrasquillo, J. A.; Fine, B. M.; Pandit-Taskar, N.; Larson, S. M.; Fleming, S. E.; Fox, J. J.; Cheal, S. M.; O'Donoghue, J. A.; Ruan, S.; Ragupathi, G.; more...
Journal of Nuclear Medicine (2019)

Fulltext@MSK | Save

Pivotal trial of enfortumab vedotin in urothelial carcinoma after platinum and anti-programmed death 1/programmed death ligand 1 therapy

Journal Article

Rosenberg, J. E.; O'Donnell, P. H.; Balar, A. V.; McGregor, B. A.; Heath, E. I.; Yu, E. Y.; Galsky, M. D.; Hahn, N. M.; Gartner, E. M.; Pinelli, J. M.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save